The Chlamydia vaccine showed promising results in an early-stage clinical trial conducted by researchers in the U.K. and Denmark. The early phase of the research found the experimental vaccine to be safe. The study was conducted from 2020 through 2022 with individuals split between non-pregnant women and men, while none had chlamydia. The researchers examined Read this story
